Everything below concerns angiotensin IV. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
=== Age === The biggest difference in blood glucose levels between the adult and pediatric population occurs in newborns during the first 48 hours of life. After the first 48 hours of life, the Pediatric Endocrine Society cites that there is little difference in blood glucose level and the use of glucose between adults and children. During the 48-hour neonatal period, the neonate adjusts glucagon and epinephrine levels following birth, which may cause temporary hypoglycemia. As a result, there has been difficulty in developing guidelines on interpretation and treatment of low blood glucose in neonates aged less than 48 hours. Following a data review, the Pediatric Endocrine Society concluded that neonates aged less than 48 hours begin to respond to hypoglycemia at serum glucose levels of 55–65 mg/dL (3.0–3.6 mmol/L). This is contrasted by the value in adults, children, and older infants, which is approximately 80–85 mg/dL (4.4–4.7 mmol/L). In children who are aged greater than 48 hours, serum glucose on average ranges from 70 to 100 mg/dL (3.9–5.5 mmol/L), similar to adults. Elderly patients and patients who take diabetes pills such as sulfonylureas are more likely to suffer from a severe hypoglycemic episode. Whipple's triad is used to identify hypoglycemia in children who can communicate their symptoms.
G. K. Fortescue, ed. (1902). "Bristol". Subject Index of the Modern Works Added to the Library of the British Museum in the Years 1881–1900. London: The Trustees. pp. 6 v. hdl:2027/uc1.b5107011. Robert Donald, ed. (1908). "Bristol". Municipal Year Book of the United Kingdom for 1908. London: Edward Lloyd. hdl:2027/nyp.33433081995593. "Bristol (England)" . Encyclopædia Britannica. Vol. 4 (11th ed.). 1911. pp. 579–582. Published in the 21st century
==== Metformin ==== One of the most common drugs used in T2D, metformin is the drug of choice to help patients lower their blood sugar levels. Metformin is an example of a class of medicine called biguanides. The medication works by reducing the new creation of glucose from the liver and by reducing absorption of sugar from food. In addition, the medication also works to help increase the effects of insulin on muscle cells, which take in glucose. The medicine is not used for T1D as these patients do not produce any insulin and metformin relies on some insulin production in order to be effective. There are several preparations of the medication such as tablets, extend release tablets, and liquid suspensions. Metformin is usually started as 500 to 1000 mg tablets twice a day by mouth (PO), usually with meals. If taking the extended release tablets, they should be always swallowed whole as cutting the tablet will cause faster release of the medication. The medication most commonly may cause side effects such as stomach upset and diarrhea, but in general is well tolerated and has a relatively low chance of causing hypoglycemia. One rare (about 1% chance) but serious side effect of metformin is that it can cause lactic acidosis, usually in patients with poor kidney function. To assist in tolerance of the metformin, practitioners may recommend gradual increase of the dose of the medication.
== Early career == Colyer was selected by Essendon with the 26th pick in the 2009 AFL draft. He previously played for Claremont in the WAFL and Trinity College, Perth. He also represented Western Australia in the 2009 AFL National Under 18 Championships and was named in the 2009 U18 All Australian team.
=== Repurposing for hair growth === When Upjohn received permission from the U.S. Food and Drug Administration (FDA) to test the new drug as medicine for hypertension they approached Charles A. Chidsey, at the University of Colorado School of Medicine. He conducted two studies, the second study showing unexpected hair growth. Puzzled by this side-effect, Chidsey consulted Guinter Kahn (who while a dermatology resident at the University of Miami had been the first to observe and report hair development on patients using the minoxidil patch) and discussed the possibility of using minoxidil for treating hair loss. Kahn, along with his colleague Paul J. Grant, had obtained a certain amount of minoxidil and conducted their own research, since they were first to make the side effect observation. Neither Upjohn or Chidsey at the time were aware of the side effect of hair growth. The two doctors had been experimenting with a 1% solution of minoxidil mixed with several alcohol-based liquids. Both parties filed patents to use minoxidil for hair loss prevention, which resulted in a decade-long trial between Kahn and Upjohn, which ended with Kahn's name included in a consolidated patent (U.S. #4,596,812 Charles A Chidsey, III and Guinter Kahn) in 1986 and royalties from the company to both Kahn and Grant. Meanwhile, the effect of minoxidil on hair loss prevention was so clear that in the 1980s physicians were prescribing Loniten off-label to their balding patients.
Sources: en.wikipedia.org
Deep sea communities around Japan are mainly researched by Japan Agency for Marine-Earth Science and Technology (JAMSTEC). DSV Shinkai 6500, Kaikō, and other groups have discovered many sites. Methane seep communities in Japan are distributed along plate convergence areas because of the accompanying tectonic activity. Many seeps have been found in the Japan Trench, Nankai Trough, Ryukyu Trench, Sagami Bay, Suruga Bay, and the Sea of Japan. Members of cold seep communities are similar to other regions in terms of family or genus, such as Polycheata, Lamellibrachia, Bivalavia, Solemyidae, Bathymodiolus in Mytilidae, Thyasiridae, Calyptogena in Vesicomyidae, and so forth. Many of the species in Japan's cold seeps are endemic. In Kagoshima Bay, there are methane gas seepages called "tagiri" (boiling). Lamellibrachia satsuma live around there. The depth of this site is only 80 m, which is the shallowest point where Siboglinidae are known to live. L. satsuma may be kept in an aquarium for a long period at 1 atm. Two aquariums in Japan are keeping and displaying L. satsuma. An observation method to introduce it into a transparent vinyl tube is being developed.
Ground coffee in cans 100% Colombian (medium roast) Black Silk (dark roast), also available in decaf Brazilian blend (medium roast) Breakfast blend (mild roast) Classic roast (medium roast), also in decaf and half caff Coffeehouse blend (medium-dark roast) Country roast (medium-dark roast) French roast (medium-dark roast) Gourmet Supreme (medium-dark roast) House blend (medium roast) Special roast (medium roast) Folgers Noir, a line of dark roast coffees Simply Smooth, a mild roast coffee intended to be gentler on the stomach, also in decaf Simply Gourmet, a line of naturally flavored coffees Folgers Flavors, French vanilla and hazelnut flavored coffees, also available as decaf hazelnut Folgers Crystals, instant coffee available in regular and decaf Coffee Singles, single-serve packets Cappuccino instant mixes K-cup pods in a variety of roasts and flavors 1850, a premium brand launched in 2018 In Canada, Folgers is primarily available as Classic Roast and Mountain Roast. In the United Kingdom, Folgers Instant Crystals are available.
The pancreas plays a vital role in the digestive system. It does this by secreting pancreatic juice, a fluid that contains digestive enzymes, into the duodenum, the first part of the small intestine that receives food from the stomach. These enzymes help to break down carbohydrates, proteins and lipids (fats). This is the exocrine role of the pancreas. The cells responsible for this are acinar cells arranged in clusters called acini. Secretions into the middle of the acinus accumulate in intralobular ducts, which drain to the main pancreatic duct, which drains directly into the duodenum. About 1.5–3 liters of fluid are secreted in this manner every day. The cells in each acinus are filled with granules containing the digestive enzymes. These are secreted in an inactive form termed zymogens or proenzymes. When released into the duodenum, they are activated by the enzyme enterokinase present in the lining of the duodenum. The proenzymes are cleaved, creating a cascade of activating enzymes.
Open water fish are usually streamlined like torpedoes to minimize turbulence as they move through the water. Reef fish live in a complex, relatively confined underwater landscape and for them, manoeuvrability is more important than speed, and many of them have developed bodies which optimize their ability to dart and change direction. Many have laterally compressed bodies (flattened from side to side) allowing them to fit into fissures and swim through narrow gaps; some use their pectoral fins for locomotion and others undulate their dorsal and anal fins. Some fish have grown dermal (skin) appendages for camouflage; the prickly leather-jacket is almost invisible among the seaweed it resembles and the tasselled scorpionfish invisibly lurks on the seabed ready to ambush prey. Some like the foureye butterflyfish have eyespots to startle or deceive, while others such as lionfish have aposematic coloration to warn that they are toxic or have venomous spines. Flatfish are demersal fish (bottom-feeding fish) that show a greater degree of asymmetry than any other vertebrates. The larvae are at first bilaterally symmetrical but they undergo metamorphosis during the course of their development, with one eye migrating to the other side of the head, and they simultaneously start swimming on their side. This has the advantage that, when they lie on the seabed, both eyes are on top, giving them a broad field of view. The upper side is usually speckled and mottled for camouflage, while the underside is pale. Some teleosts are parasites.
==== LL Cool J ==== Ice-T had a feud with LL Cool J in the late 1980s and early 1990s. Apparently, this was instigated by LL's claim to be "the baddest rapper in the history of rap itself". Ice-T recorded disses against LL on his 1988 album Power. On the album was the track, "I'm Your Pusher", in which a rap music addict declines to buy an LL Cool J record. In the book Check the Technique: Liner Notes for Hip-Hop Junkies, Ice-T said that the song "Girls L.G.B.N.A.F." was also intended as a diss to LL Cool J, by making a crude song to contrast with the love songs that LL was making at the time. On LL's response, "To da Break of Dawn" in 1990, he dissed Kool Moe Dee (whose feud with LL was far more publicized) as well as MC Hammer. He then devoted the third verse of the song to dissing Ice-T, mocking his rap ability ("take your rhymes around the corner to rap rehab"), his background ("before you rapped, you was a downtown car thief"), and his style ("a brother with a perm deserves to get burned"). He also suggested that the success of Power was due to the appearance of Ice-T's girlfriend Darlene on the album cover. Ice-T appeared to have ignored the insults and he had also defended LL Cool J after his arrest in the song "Freedom of Speech". In August 2012, Ice-T said that the rivalry was "never serious" and that he needed a nemesis to create "an exciting dispute".
Sources: en.wikipedia.org
=== Non refractive roles of crystallins in lens and cornea === While it is evident that gene sharing resulted in many of lens crystallins being multifunctional proteins, it is still uncertain to what extent the crystallins use their non-refractive properties in the lens, or on what basis they were selected. The α-crystallins provide a convincing case for a lens crystallin using its non-refractive ability within the lens to prevent protein aggregation under a variety of environmental stresses and to protect against enzyme inactivation by post-translational modifications such as glycation. The α-crystallins may also play a functional role in the stability and remodeling of the cytoskeleton during fiber cell differentiation in the lens. In cornea, ALDH3 is also suggested to be responsible for absorbing UV-B light.
Peart has been voted the greatest rock drummer by music fans, critics and fellow musicians, according to Drummerworld. He was also regarded as one of the finest practitioners of the in-concert drum solo. Initially inspired by Keith Moon, Peart absorbed the influence of other rock drummers from the 1960s and 1970s such as Ginger Baker, Carmine Appice, and John Bonham. Incorporation of unusual instruments (for rock drummers of the time) such as the glockenspiel and tubular bells, along with several standard kit elements, helped create a highly varied setup. Continually modified, Peart's drumkit offered an enormous array of percussion instruments for sonic diversity. For two decades Peart honed his technique; each new Rush album introduced an expanded percussive vocabulary. In the 1990s, he reinvented his style with the help of drum coach Freddie Gruber. Peart served as Rush's primary lyricist, attracting attention over the years for his eclectic style. During the band's early years, Peart's lyrics were largely fantasy/science fiction-focused, though after 1980 he focused more on social, emotional, and humanitarian issues. In 2007, he was placed second on Blender magazine's list of the "40 Worst Lyricists in Rock". In contrast, AllMusic has called Peart "one of rock's most accomplished lyricists", Gibson.com describes Rush's lyrics as "great", and others have called the lyrics "brilliant".
=== Pentomic organization === In 1957, the division implemented the pentomic organization, officially Reorganization of the Airborne Division (ROTAD), to better prepare for tactical nuclear war in Europe. Five battle groups, each with a headquarters and service company, five rifle companies and a mortar battery, replaced the division's three regiments of three battalions each. The division's battle groups were:
The genes were compared to those of thousands of other species and while blocks of three or more genes co-occurred between squid and octopus, the blocks of genes were not found together in any other animals'. Many of the groupings were in the nervous tissue, suggesting the course they adapted their intelligence.
Richard Carthew et al. state in their 2004 study of siRNA/miRNA silencing pathways in Drosophila that siRNA-induced post-transcriptional gene silencing is initiated by the assembly of the RNA-induced silencing complex (RISC). RISC silences expression of certain genes by cleaving the mRNA molecules coding those genes. To begin the process in that system, they state that one of the two siRNA strands, the anti-sense guide strand, is loaded into the RISC while the other strand, the sense passenger strand, is degraded; they go on to state that certain Drosophila Dicer enzymes may be responsible for loading the guide strand into RISC. Then, in a perspective from 2009, the view is offered that "siRNA scans for and directs RISC" to a perfectly complementary sequence on the mRNA molecules. The cleavage of the mRNA molecules is thought to be catalyzed by the Piwi domain of Argonaute proteins of the RISC; the mRNA molecule is then cut precisely by cleaving the phosphodiester bond between the target nucleotides which are paired to siRNA residues 10 and 11, counting from the 5'end. As Orban and Izaurralde note with regard to a further study in Drosophila cells, "[f]ollowing this initial endonucleolytic cleavage, the mRNA is [further] degraded" by cellular exonucleases; they show that in this system, the 5' fragments "are rapidly degraded from their 3' ends by the exosomes, whereas the 3' fragments are degraded from their 5' ends by XRN1", a 5'-3' exoribonuclease.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.